LivaNova has been granted a patent for a cardiopulmonary bypass perfusion system featuring a fluid reservoir with an RFID tag, an imaging device to detect the tag, and a controller that processes information from the imaging device to manage fluid volume and operating parameters. GlobalData’s report on LivaNova gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on LivaNova, Wearable defibrillators was a key innovation area identified from patents. LivaNova's grant share as of June 2024 was 66%. Grant share is based on the ratio of number of grants to total number of patents.
Cardiopulmonary bypass perfusion system with rfid and imaging
The granted patent US12036349B2 outlines a cardiopulmonary bypass perfusion system that integrates advanced technology to enhance the management of fluid reservoirs used in medical procedures. Central to this system is a fluid reservoir equipped with a radio-frequency identification (RFID) tag, which allows for the identification and monitoring of the reservoir's contents. An imaging device with an identification sensor detects the RFID tag, enabling a controller to access critical information about the fluid reservoir. This system is designed to determine fluid volume, display it through a graphical user interface (GUI), and facilitate user interactions for setting alarm levels and fluid volume parameters.
Additionally, the controller is capable of utilizing the data from the RFID tag to confirm the suitability of the fluid reservoir for specific applications, detect potential equipment mismatches, and manage operational parameters. The RFID tag can store various data, including design specifications and expiration dates, which the controller can use to configure or operate associated heart-lung machines effectively. The system also features a virtual curtain in the imaging device to assist in positioning relative to the fluid reservoir, further enhancing operational efficiency. Overall, this innovative system aims to improve the safety and effectiveness of cardiopulmonary bypass procedures by leveraging RFID technology and advanced imaging capabilities.
To know more about GlobalData’s detailed insights on LivaNova, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
